Cell engineering biointerface focusing on cytocompatibility using phospholipid polymer with an isomeric oligo(lactic...

Area of Science:

• Biomaterials Science
• Polymer Chemistry
• Surface Science

Background:

• The performance of biomaterials in vivo is determined by their initial interaction with the biological environment.
• Developing sophisticated biointerfaces is crucial for creating novel biomaterials and advanced biomedical devices like biochips and nanoparticles.
• Surface properties of polymeric biomaterials can be tailored for specific applications.

Purpose of the Study:

• To design and evaluate novel phospholipid polymers with isomeric oligo(lactic acid) segments as biointerfaces.
• To investigate the influence of different oligo(lactic acid) isomers on protein adsorption and cell adhesion.
• To assess the cytocompatibility and cell adhesion properties of the developed biointerfaces.

Main Methods:

• Copolymerization of 2-methacryloyloxyethyl phosphorylcholine with isomeric oligo(lactic acid) macromonomers.
• Formation of thin coating membranes from the synthesized polymers to serve as biointerfaces.
• Evaluation of biological responses, including protein adsorption and cell adhesion, by varying the oligo(lactic acid) component.
• Assessment of cell viability using metabolic activity assays.

Main Results:

• The synthesized phospholipid polymers readily formed thin coating membranes suitable for biointerfaces.
• The oligo(lactic acid) segments formed hydrophobic domains, enhancing protein adsorption and cell adhesion.
• A dual function was observed: cytocompatibility from the phospholipid polymer and cell adhesion from the oligo(lactic acid) segment.
• Different isomers of oligo(lactic acid) influenced biological responses on the biointerface.

Conclusions:

• Phospholipid polymers incorporating isomeric oligo(lactic acid) segments are effective for creating advanced biointerfaces.
• The designed biointerfaces exhibit tunable properties for regulating cell-material interactions.
• These materials hold promise for applications in biomedical devices requiring controlled biological responses.